NLS Pharmaceutics AG

NASDAQ (USD): NLS Pharmaceutics AG (NLSP)

Last Price

0.197

Today's Change

-0.008 (3.90%)

Day's Change

0.196 - 0.208

Trading Volume

616,039

Overview

Market Cap

9 Million

Shares Outstanding

46 Million

Avg Volume

10,139,706

Avg Price (50 Days)

0.16

Avg Price (200 Days)

0.38

PE Ratio

-0.62

EPS

-0.32

Earnings Announcement

28-Aug-2024

Previous Close

0.20

Open

0.20

Day's Range

0.1958 - 0.2076

Year Range

0.111 - 1.205

Trading Volume

616,092

Price Change Highlight

1 Day Change

-3.85%

5 Day Change

-1.45%

1 Month Change

58.19%

3 Month Change

31.75%

6 Month Change

-62.10%

Ytd Change

-66.47%

1 Year Change

-78.10%

3 Year Change

-93.45%

5 Year Change

-93.18%

10 Year Change

-93.18%

Max Change

-93.18%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment